Rosiglitazone to Reverse Metabolic Defects in Diabetes
Clinical trial NCT00094796 · COMPLETED
Trial details
- NCT number
- NCT00094796
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-20
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.